Your browser doesn't support javascript.
loading
Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.
Wachsmuth, Lucas P; Patterson, Michael T; Eckhaus, Michael A; Venzon, David J; Gress, Ronald E; Kanakry, Christopher G.
Afiliación
  • Wachsmuth LP; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI).
  • Patterson MT; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI).
  • Eckhaus MA; Division of Veterinary Resources, Office of Research Services.
  • Venzon DJ; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Gress RE; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI).
  • Kanakry CG; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI).
J Clin Invest ; 129(6): 2357-2373, 2019 03 26.
Article en En | MEDLINE | ID: mdl-30913039

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T Reguladores / Trasplante de Células Madre Hematopoyéticas / Ciclofosfamida / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Revista: J Clin Invest Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T Reguladores / Trasplante de Células Madre Hematopoyéticas / Ciclofosfamida / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Revista: J Clin Invest Año: 2019 Tipo del documento: Article
...